| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 23 |
| 1 | METHOTREXATE | 20 |
| 2 | ASPIRIN | 19 |
| 3 | ASPIRIN 325 MG | 18 |
| 4 | ASPIRIN 81 MG | 18 |
| 5 | PREDNISOLONE | 13 |
| 6 | PREDNISOLONE ORAL | 13 |
| 7 | PREDNISOLONE ORAL SOLUTION | 13 |
| 8 | ETANERCEPT | 12 |
| 9 | INFLIXIMAB | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PHENTOLAMINE MESYLATE | 1 | 0.0062 |
| 1 | MINERAL OIL | 5 | 0.0034 |
| 2 | HYDROXOCOBALAMIN | 6 | 0.0014 |
| 3 | PENTOXIFYLLINE | 6 | 0.0014 |
| 4 | CEDAZURIDINE AND DECITABINE | 1 | 0.0010 |
| 5 | FINGOLIMOD HYDROCHLORIDE | 5 | 0.0010 |
| 6 | HALOBETASOL PROPIONATE | 1 | 0.0007 |
| 7 | WHITE PETROLATUM | 1 | 0.0007 |
| 8 | HYALURONATE SODIUM | 1 | 0.0007 |
| 9 | DOXYCYCLINE MONOHYDRATE | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 35 |
| 1 | Corticosteroid [EPC] | 32 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 24 |
| 3 | Proton Pump Inhibitor [EPC] | 21 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 20 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 19 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 17 |
| 7 | Vitamin C [EPC] | 13 |
| 8 | Benzodiazepine [EPC] | 12 |
| 9 | Factor Xa Inhibitor [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Blood Viscosity Reducer [EPC] | 6 | 0.0014 |
| 1 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 4 | 0.0003 |
| 2 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 2 | 0.0003 |
| 3 | Vitamin K [EPC] | 2 | 0.0002 |
| 4 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 6 | Tetracycline-class Drug [EPC] | 9 | 0.0001 |
| 7 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 3 | 0.0001 |
| 8 | Macrolide Antimicrobial [EPC] | 6 | 0.0001 |
| 9 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |